ReACanROC:创建法国-加拿大院外心脏骤停研究网络
法国纳入55358例、加拿大约33688例成人非创伤性且接受治疗的院外心脏骤停病例,估计发病率分别为75.3/10万和83/10万。两国患者均以男性、近七十岁、家中发病、推测心源性病因为主,旁观者心肺复苏约半数;可电击初始心律法国16% vs 加拿大22%,专业复苏尝试法国82% vs 加拿大60%。院前组织差异包括法国医师主导高级生命支持、加拿大训练有素急救员,呼叫至首批专业救援到达时间加拿大6.5分钟(IQR 5.2-8.3)vs 法国10分钟(IQR 7-15),出院存活率法国5% vs 加拿大11%。作者拟于2020年建立ReACanROC研究网络以进一步分析变异预测因素。
要点
- 出院存活率:法国5% vs 加拿大11%,两国院前急救体系不同可能解释结局差异。
- 呼叫至首批专业救援到达时间:加拿大6.5分钟(IQR 5.2-8.3)vs 法国10分钟(IQR 7-15)。
- 可电击初始心律:法国16% vs 加拿大22%;专业复苏尝试:法国82% vs 加拿大60%。
- 估计发病率:法国75.3/10万 vs 加拿大83/10万(2011-2016年成人非创伤性治疗病例)。
- 两国均以男性、近七十岁、家中发病、推测心源性病因为主,旁观者心肺复苏约半数。
适用人群与场景
- 法国和加拿大全国性、基于人群的Utstein式前瞻性院外心脏骤停登记中2011至2016年成人、非创伤性、接受治疗的院外心脏骤停病例。
研究设计与关键结果
- 研究类型为两个全国性、基于人群的Utstein式前瞻性院外心脏骤停登记(法国RéAC、加拿大CanROC)的初步比较描述,数据取自2011至2016年。
- 自登记创建以来,法国纳入103722例,加拿大约99317例;本分析纳入成人非创伤性治疗病例法国55358例、加拿大约33688例。
- 估计发病率:法国75.3/10万居民,加拿大83/10万居民。
- 两国院外心脏骤停均以男性、近七十岁、家中发病、推测心源性病因为主;旁观者心肺复苏约半数病例。
- 可电击初始心律:法国16% vs 加拿大22%。
- 专业复苏尝试:法国82% vs 加拿大60%。
- 院前组织差异:法国为医师主导的高级生命支持,加拿大为训练有素的急救员;呼叫至首批专业救援到达现场时间加拿大6.5分钟(IQR 5.2-8.3)vs 法国10分钟(IQR 7-15)。
- 院外干预、转送医院类型(法国系统性绕过急诊科、优先三级医院;加拿大偶尔绕过、优先最近医院)及结局不同:出院总存活率法国5% vs 加拿大11%。
证据类型、等级与局限
- 证据类型:两个全国性、基于人群、Utstein式前瞻性实施的院外心脏骤停登记(法国RéAC、加拿大CanROC)的初步比较描述。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,尽管部分院外心脏骤停Utstein变量相似,法国与加拿大院前体系及结局仍存在差异。
- 作者认为,创建ReACanROC研究网络将促进进一步分析,以更好地理解这种变异的预测因素。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
- 另有 2 条提炼内容因数值无法与原文逐一核对而未列出,请以原文为准。
英文原文(摘要)· 点击展开
AIMS: There are large differences between emergency medical systems, which may account for variability in outcomes. We seek to compare prehospital organizations, response modes, patient characteristics and outcomes after out-of-hospital cardiac arrest, between France and Canada, and discuss the need for the first European-North American prehospital research network on out-of-hospital cardiac arrest.
METHODS: Preliminary comparative description of data drawn from two nation-wide, population-based, Utstein-style prospectively implemented registries for out-of-hospital cardiac arrest in France and Canada (France: RéAC, Canada: CanROC), covering approximately 80 million people, and soon to be participating in an international research network in 2020.
RESULTS: Since creation, 103,722 cases were included in France and approximately 99,317 in Canada. Data used in this work were drawn from 2011 to 2016, and comprised around 33,688 adult, non-traumatic, treated cases in Canada, and 55,358 in France, leading to estimated incidence rates of 75.3/100,000 inhabitants in France and 83/100,000 in Canada. In both countries, out-of-hospital cardiac arrest predominantly occurred in male patients, in their late sixties, at home, of presumed cardiac aetiology. Bystander cardiopulmonary resuscitation was provided in half of the cases. First assessed cardiac rhythm was shockable in 16% (France) vs. 22% (Canada). Professional resuscitation was attempted in 82% (France) and 60% (Canada). Prehospital organizations and response modes differed in the constitution of responding teams (France: physician-led advanced life support, Canada: trained paramedics), in response time intervals (call to first professional responders' arrival at scene 6.5 min (interquartile range IQR [5.2-8.3]) (Canada) vs. 10 min [7-15] (France)), in on-scene interventions, type of referral at hospital (France: systematic bypass of emergency department, tertiary hospital first, Canada: occasional bypass, mainly closest hospital first), and in outcomes (overall survival at hospital discharge in France: 5% vs. Canada: 11%).
CONCLUSION: Despite similarities in some out-of-hospital cardiac arrest Utstein variables, several differences exist between French and Canadian prehospital systems, and ultimately, between outcomes. The creation of the ReACanROC research network will facilitate the conduction of further analyses to better understand predictors of this variability.
参考来源
- Heidet M, Fraticelli L, Grunau B, et al. ReACanROC: Towards the creation of a France-Canada research network for out-of-hospital cardiac arrest. Resuscitation. 2020. PMID: 32422245. doi:10.1016/j.resuscitation.2020.05.008
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。